Embedded Files
Rheum Dis 1998;57:378-9. 18. Kanis JA, Johnell O, Oden A, et al. Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 2000;11:669-74. 19. Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL. Perspective: how many women have osteoporosis? J Bone Miner Res 1992;7:1005-10. 20. Lauritzen JB, Schwarz P, Lund B, McNair P, Transbol I. Changing incidence and residual lifetime risk of common osteoporosis-related fractures. Osteoporos Int 1993; 3:127-32. 21. Cooper C. The crippling consequences of fractures and their impact on quality of life. Am J Med 1997;103:12-17. 22. Gehlbach SH, Bigelow C, Heimisdottir M, et al. Recognition of vertebral fracture in a clinical setting. Osteoporos Int 2000;11:577-82. 23. Riggs BL, Melton LJ III. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995;17(Supp 5):505-11. 24. Jordan KM, Cooper C. Epidemiology of osteoporosis. Best Pract Res Clin Rheumatol 2002;16:795-806. 25. Wildner M, Clark DE. Hip fracture incidence in East and West Germany: reassessment ten years after unification. Osteoporos Int 2001;12:136-9. 26. International Osteoporosis Foundation. Osteoporosis in the European _report.html (accessed 25/05/04). 27. Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992;2:285-9. 28. Cummings SR, Rubin SM, Black D. The future of hip fractures in the United States: numbers, costs, and potential effects of postmenopausal estrogen. Clin Orthop 1990; 252:163-6. 29. Johnell O. The socioeconomic burden of fractures: today and in the 21st century. Am J Med 1997;103:20-5. mprovement of Osteoporosis Medication after Multimodal Intervention in Patients with Hip Fracture: Prospective Multicenter Study Yong-Geun Park1 , Kwang Woo Nam1 , Sang-Rim Kim1 , Min-Suk Park2 , Sang-Jae Kim2 , Yong-Chan Ha3 1 Department of Orthopaedic Surgery, Jeju National University Hospital, Jeju National University School of Medicine, Jeju; 2 Department of Orthopedic Surgery and Traumatology, Cheju Halla General Hospital, Jeju; 3 Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea Background: The authors had earlier conducted a retrospective cohort study from 2008 to 2011 in Jeju Island, among 945 hip fracture patients above 50 years of age. Of these 945 patients, 344 patients (36.4%) underwent a bone mineral density test and 218 patients (23.1%) received treatment for osteoporosis. The purpose of this study was to determine whether a patient education program could improve osteoporosis management after hip fracture. The data of the previous study was used for comparison. Methods: From November 1, 2014 to September 30, 2015, 190 patients above 50 years of age who were admitted for hip fractures at six different hospitals, were enrolled in the present study. During the hospitalization period, patients underwent education sessions and were provided brochures. Patients were evaluated for diagnosis and treatment of osteoporosis at six months after discharge and were followed-up for at least a year. Results: Of the 222 patients with hip fractures, 190 patients (37 men, 153 women) were enrolled at six hospitals in 2015. Dual energy X-ray absorptiometry was performed on 115 patients (60.5%) and 92 patients (48.4%) were prescribed medication for osteoporosis at the time of discharge. A total of 43.7% and 40.2% of the patients were found to be compliant with osteoporosis medication at 6 months and 12 months follow-up respectively. Conclusions: This interventional multicenter study demonstrated that a patient education program in patients with hip fractures can improve compliance to osteoporosis medication up to 12 months of follow-up. Key Words: Hip fractures, Osteoporosis, Patient education as topic, Therapeutics INTRODUCTION Hip fracture is most serious complication of osteoporosis related fractures and is associated with several adverse effects in the elderly. The incidences of hip fracture in global populations are reporting that number and incidence of hip fracture are increasing trends.[1] In Korea, numbers and incidence of hip fracture is also expected increasing trend until 2026.[2] Hip fractures are notorious high mortality, morbidity, secondary hip fracture, and considerable socioeconomic burdens.[3-5] To minimize complications after hip fracture, appropriate osteoporosis medication are recommend to reduce risks of subsequent fractures and mortality.[6-8] Corresponding author Yong-Chan Ha Department of Orthopaedic Surgery, ChungAng University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea Tel: +82-2-6299-1591 Fax: +82-2-822-1710 E-mail: hayongch@naver.com Received: March 29, 2018 Revised: May 13, 2018 Accepted: May 16, 2018 No potential conflict of interest relevant to this article was reported. Original Article J Bone Metab 2018;25:107-113 However, treatment rates after osteoporotic fracture are still insufficient.[9,10] To improve diagnosis and treatment rate of osteoporosis, physician, patients, and reimbursement system are very important.[11] Previously we reported
Google Sites
Report abuse